Buprenorphine hydrochloride is a partial opioid agonist. Buprenorphine hydrochloride injection is indicated for the management of pain severe enough to require an opioid analgesic and for which alternate treatments are inadequate.
Because of the risks of addiction, abuse, and misuse with opioids, even at recommended doses, reserve buprenorphine for use in patients for whom alternative treatment options have not been tolerated, or are not expected to be tolerated, have not provided adequate analgesia, or are not expected to provide adequate analgesia.
Buprenorphine hydrochloride injection contains buprenorphine, a Schedule III controlled substance. As an opioid, buprenorphine exposes users to the risks of addiction, abuse, and misuse. DEA Schedule CIII. Route of Administration: Intramuscular, Intravenous. 5 ampules per box.
This is a CIII RX and requires a DEA Form 222 in order to fulfill.